Teladoc Health (NYSE:TDOC) Reaches New 52-Week Low After Analyst Downgrade

Shares of Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) reached a new 52-week low during trading on Monday after Citigroup lowered their price target on the stock from $11.00 to $8.75. Citigroup currently has a neutral rating on the stock. Teladoc Health traded as low as $6.38 and last traded at $6.45, with a volume of 2474952 shares trading hands. The stock had previously closed at $6.83.

Several other equities research analysts have also issued reports on TDOC. Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a report on Thursday, February 27th. The Goldman Sachs Group cut their target price on Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a report on Monday, March 3rd. Jefferies Financial Group decreased their target price on shares of Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a research report on Monday, April 21st. Royal Bank of Canada lifted their price objective on Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Finally, Piper Sandler dropped their target price on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Twelve equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $10.71.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the transaction, the insider now owns 64,308 shares of the company's stock, valued at approximately $541,473.36. This represents a 14.62 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.58% of the stock is owned by insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Robeco Institutional Asset Management B.V. raised its position in shares of Teladoc Health by 21.8% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider's stock valued at $6,365,000 after buying an additional 125,111 shares during the last quarter. Versant Capital Management Inc increased its position in Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock valued at $29,000 after acquiring an additional 2,441 shares during the last quarter. Nisa Investment Advisors LLC raised its position in Teladoc Health by 20,936.8% in the 4th quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider's stock worth $3,874,000 after purchasing an additional 424,180 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in Teladoc Health by 18.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider's stock worth $22,213,000 after purchasing an additional 384,528 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in Teladoc Health by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock valued at $35,894,000 after acquiring an additional 22,664 shares during the period. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Price Performance

The stock has a market capitalization of $1.26 billion, a PE ratio of -1.25 and a beta of 1.73. The stock's 50 day moving average price is $8.52 and its 200-day moving average price is $9.57. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. As a group, equities analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.